Webinar

The key to unlocking maximum OEE? Integrating dosing accuracy, platen sealing, magnetic shuttle transport, and automated 100% in-line quality control into a unified workflow. Join our virtual event, "How to Achieve Stable, High-Output Stickpack Production" with packaging expert René Schubert (Körber Pharma). Why you can't afford to miss this: - Discover how integrated stickpack &...

Mesenchymal stromal cell (MSC) therapies are entering a pivotal stage of development. As more programs move toward late-stage clinical trials and commercialization, developers must produce enough high-quality cells to meet growing demand while maintaining potency, consistency, and manufacturability. How can companies scale MSC production without compromising the biological properties that drive therapeutic efficacy? Join Cell...

Lipid nanoparticles (LNPs) are critical to the delivery of genetic medicines, but developing scalable, reproducible manufacturing processes remains complex and resource-intensive. Because LNP quality can be highly sensitive to formulation and processing conditions, identifying the right parameters efficiently is essential. This webinar will explore how impinging jet mixing, automation, inline analytics, and data-driven optimization can...

Strategies for supply assurance, QC readiness, digital optimization, and commercial bioprocessing success. The translation of cell culture processes from laboratory-scale development to commercial manufacturing remains one of the most critical challenges in bioprocessing. While small-scale systems provide valuable insights into cell growth, productivity, and product quality, scale-up introduces complex engineering and biological variables that can...

Join us for an exclusive webinar exploring practical strategies to improve therapeutic antibody manufacturing through integrated upstream and downstream process solutions. As therapeutic antibody titers continue to rise, manufacturers face increasing pressure to remove harvest bottlenecks, improve purification efficiency, and maintain product quality while controlling manufacturing costs. Successfully integrating upstream and downstream operations has become...

As the December 1, 2026 release of the revised USP <87>, Biological Reactivity Tests, In Vitro, approaches, pharmaceutical and medical device manufacturers should begin evaluating how these changes may impact their material qualification, biological evaluation, and compliance strategies. While the final chapter has not yet been published, the proposed direction reflects a broader industry shift...

A risk-averse investment climate has made it more difficult for startups to find the funding needed to bring novel treatments into the clinic. However, alternative funding sources, investment models, and nontraditional investors are stepping in to fill the void. Our panel of experts will identify and discuss new funding opportunities and strategies for companies at...

Virtual Pharma Expo - a themed event featuring presentations and demonstrations by leading experts from pharmaceutical equipment providers for oral solid dose manufacturing and packaging.

Innovations in self-administered and wearable drug delivery technologies promise convenience but bring questions about how to effectively monitor and manage patient safety, adherence, dosing accuracy, and, ultimately, medical outcomes. In this live online session, expert panelists will discuss approaches to leveraging the power of digital tools to provide feedback loops and administrative controls. From both...

Transitioning development processes into GMP manufacturing can come with a fair share of growing pains. Development teams need to contend with things like sourcing and validating new materials, ensuring regulatory compliance, performing risk assessments, and evaluating facility fit. Unexpected challenges in any aspect of this transition can be costly and delay a product’s time to...

For cell therapy developers, manufacturing success starts well before a process enters a GMP cleanroom. Decisions around donor and material sourcing, collection strategy, starting material specifications, process development, and analytical strategy can directly influence process consistency, technology transfer, and manufacturing readiness. Join technical experts from New York Blood Center Enterprises’ Comprehensive Cell Solutions (CCS) team...